billS3816•Event Tuesday, February 10, 2026Analyzed

Repair Abuses of MSP Payments (RAMP) Act

Bearish

Impact4/10

UnitedHealth Group ($UNH)Cigna Group ($CI)Humana ($HUM)CVS Health ($CVS)Healthcare

Summary

The RAMP Act, S.3816, is in the early stages of the legislative process, having been referred to the Senate Committee on Finance on February 10, 2026. This bill aims to restrict private rights of action for Medicare Secondary Payer (MSP) violations solely to group health plans, thereby reducing legal exposure for workers' compensation, automobile, liability, and no-fault insurers. This change would shift potential legal liabilities and associated costs more directly onto group health plans.

Key Takeaways

1.The RAMP Act (S.3816) restricts private rights of action for Medicare Secondary Payer violations to only group health plans.
2.This bill would reduce legal exposure and litigation costs for workers' compensation, automobile, liability, and no-fault insurers.
3.Group health plans, including those operated by $UNH, $CI, $HUM, and $CVS, would face increased potential legal liability.
4.The bill is in the early committee stage, with a companion bill (HR4056) also introduced in the House.

Market Implications

The RAMP Act, if enacted, would structurally increase the legal and compliance burden on companies operating group health plans. While the bill is in its early legislative stages, its progression could lead to increased operational costs or potential legal settlements for major players like UnitedHealth Group Incorporated ($UNH), The Cigna Group ($CI), Humana Inc. ($HUM), and CVS Health Corporation ($CVS). Conversely, insurers primarily focused on non-group health segments would see a reduction in a specific area of legal risk. Current market performance for these tickers shows positive 7-day and 30-day trends for $UNH, $CI, and $HUM, and a positive 7-day trend for $CVS, which does not yet reflect specific market reaction to this early-stage bill.

Full Analysis

The Repair Abuses of MSP Payments (RAMP) Act (S.3816) was introduced in the Senate on February 10, 2026, and subsequently referred to the Committee on Finance. This bill, sponsored by Senator Tim Scott (R-SC) and cosponsored by one other senator, seeks to amend Section 1862(b)(3)(A) of the Social Security Act. The core change is to replace "primary plan" with "group health plan (as defined in paragraph (1)(A)(v))" in the context of private causes of action for damages related to Medicare Secondary Payer (MSP) violations. A companion bill, HR4056, has also been introduced in the House, indicating a coordinated legislative effort. This bill does not authorize or appropriate any specific funding amount. Instead, it redefines legal liability within the healthcare insurance landscape. The mechanism is regulatory relief for certain types of insurers by narrowing the scope of private rights of action. This means that workers' compensation, automobile, liability, and no-fault insurers would face significantly reduced litigation risk and associated costs related to MSP violations. Conversely, group health plans would become the sole target for such private rights of action, potentially increasing their legal exposure and compliance burdens. Structural winners under this legislation would be insurers primarily focused on workers' compensation, automobile, liability, and no-fault policies, as their legal risks related to MSP would decrease. Structural losers are group health plans, which would bear the full weight of private rights of action for MSP violations. Companies like UnitedHealth Group Incorporated ($UNH), The Cigna Group ($CI), Humana Inc. ($HUM), and CVS Health Corporation ($CVS), which operate significant group health plan segments, would face increased potential liability. The bill is in an early stage, requiring committee approval, potential floor votes in both chambers, and presidential assent. Recent market data shows varied performance for major group health plan providers. UnitedHealth Group Incorporated ($UNH) is currently at $302.48, up +11.79% over the last 7 days and +5.59% over 30 days. The Cigna Group ($CI) is at $274.52, with a 7-day change of +2.91% and a 30-day change of +1.06%. Humana Inc. ($HUM) is at $191.78, showing a +10.61% increase over 7 days and +7.05% over 30 days. CVS Health Corporation ($CVS) is at $76.17, up +6.06% over 7 days but down -2.25% over 30 days. These recent movements do not appear to directly reflect the RAMP Act's introduction, given its early legislative stage and the broader market factors influencing these large-cap healthcare companies.

Market Impact Score

4/10

Minimal ImpactModerateMajor Market Event

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

BillStrong LinkBullish

Capping Costs for Consumers Act of 2026

Shared: Health Plans · Cigna Group · Humana Inc· Both mention $UNH, $CI, $HUM41% match

4/10

BillStrong LinkBearish

To amend title XXVII of the Public Health Service Act and the Patient Protection and Affordable Care Act to provide for certain reforms with respect to medical loss ratios and reducing fraudulent enrollment in qualified health plans.

Shared: Cigna Group · Humana Inc · Health· Both mention $UNH, $CI, $HUM38% match

4/10

BillStrong LinkNeutral

Veteran Caregiver Reeducation, Reemployment, and Retirement Act

Shared: Cigna Group · Humana Inc· Both mention $CVS, $UNH, $HUM37% match

4/10

BillStrong LinkBullish

A bill to ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.

Shared: Cigna Group · Humana Inc · Health· Both mention $CI, $HUM, $CVS35% match

3/10

BillStrong LinkBullish

Increasing Access to Lung Cancer Screening Act